| scholarly article | Q13442814 |
| MDMA | Q69488 |
| P2093 | author name string | Andrew C Parrott | |
| John J D Turner | |||
| Lynn T Singer | |||
| Meeyoung O Min | |||
| Sarah Fulton | |||
| Derek G Moore | |||
| Julia Goodwin | |||
| P2860 | cites work | Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy | Q24612266 |
| Townes-Brocks syndrome | Q33537397 | ||
| Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood | Q33923851 | ||
| (+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty. | Q33923856 | ||
| Developmental effects of 3,4-methylenedioxymethamphetamine: a review | Q33923930 | ||
| Cognitive and motor outcomes of cocaine-exposed infants | Q33958652 | ||
| Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study | Q34030711 | ||
| The drug abuse screening test | Q34280814 | ||
| Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. | Q34466994 | ||
| Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat. | Q35713639 | ||
| MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress | Q36410784 | ||
| During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. | Q36587829 | ||
| Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes | Q36617655 | ||
| The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release | Q36862351 | ||
| Long-term behavioral consequences of prenatal MDMA exposure | Q37113799 | ||
| 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. | Q43581726 | ||
| Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems | Q43858335 | ||
| Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats | Q44583496 | ||
| Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning. | Q45068756 | ||
| Congenital anomalies after prenatal ecstasy exposure. | Q55033389 | ||
| [Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM)] | Q74622743 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 407-413 | |
| P577 | publication date | 2012-08-20 | |
| P1433 | published in | Pediatrics | Q7159238 |
| P1476 | title | One-year outcomes of prenatal exposure to MDMA and other recreational drugs | |
| P478 | volume | 130 |
| Q26830011 | A review of environmental contributions to childhood motor skills |
| Q37138642 | Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies |
| Q38123779 | Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspective |
| Q26996076 | Contributions of a Child's Built, Natural, and Social Environments to Their General Cognitive Ability: A Systematic Scoping Review |
| Q37411953 | Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK. |
| Q50532543 | Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study. |
| Q38720375 | Heightened sympathetic arousal is demonstrated by skin conductance responsivity to auditory stimuli in a small cohort of neonates with opiate withdrawal |
| Q34359604 | Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research |
| Q40300253 | Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone? |
| Q38178521 | MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy. |
| Q34407992 | MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014). |
| Q36680061 | Motor delays in MDMA (ecstasy) exposed infants persist to 2 years. |
| Q48972519 | Novel psychoactive substances: second and third international conferences |
| Q37719523 | Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years |
| Q37416916 | Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy |
| Q35489276 | Psychostimulants and movement disorders |
| Q38665183 | Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospects. |
| Q30835700 | Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. |
| Q38555614 | Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation |
Search more.